KENDRA FLEENER: Open Payments
NPI 1871204172 · BEAVER DAM, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 48 payments from 15 companies in 2025. Trend: 2023 $25 · 2024 $403 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 11 | $257 |
| ABBVIE INC. | 18 | $205 |
| Novo Nordisk Inc | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Ardelyx, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Alkermes, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $25 |
Products named: Korlym, VRAYLAR, Wegovy, UBRELVY, QULIPTA, Kerendia, REXULTI, Auvelity.
Industry payments across KY — which companies pay providers there.
